**Core Concept:**
CANCA stands for Canavan Disease, a rare, inherited disorder affecting the central nervous system. It is caused by a deficiency of aspartoacylase enzyme, which leads to the accumulation of N-acetylaspartate (NAA) and aspartoacylase within oligodendrocytes. CANCA Positivity indicates the presence of elevated NAA levels in cerebrospinal fluid (CSF).

**Why the Correct Answer is Right:**
The correct answer, CANCA Positivity, is specific for Canavan Disease because the elevated N-acetylaspartate levels in CSF are a distinctive biochemical marker for this disorder. Aspartoacylase deficiency causes accumulation of NAA, which is selectively toxic to oligodendrocytes, leading to their death and subsequent demyelination in the brain. This specific pathological process results in the characteristic clinical features of Canavan Disease.

**Why Each Wrong Option is Incorrect:**
A. CANCA Negativity does not rule out Canavan Disease, as other leukodystrophies can present with similar CSF findings. However, it is less likely for other conditions.

B. Elevated NAA levels in CSF can be found in several other disorders, particularly in leukodystrophies. However, the combination of other findings, such as normal or slightly elevated protein, low or absent choline, and elevated lactate, should help differentiate Canavan Disease from these conditions.

C. CANCA Positivity is not specific to Canavan Disease. Elevated NAA levels in CSF can be found in various neurologic disorders. However, the clinical context and supportive findings are essential to differentiate Canavan Disease from other leukodystrophies and neurological disorders.

D. CANCA Positivity is not specific to Canavan Disease, as other leukodystrophies and neurological disorders can have similar CSF findings. However, the clinical context and supportive findings can help differentiate these conditions and guide appropriate management and prognosis.

**Clinical Pearl / High-Yield Fact:**
While elevated NAA levels in CSF are not specific to Canavan Disease, it is essential to consider this finding in the context of the appropriate clinical presentation and supportive findings. This allows for a more accurate diagnosis and appropriate management of the patient. The correct interpretation of CSF biomarkers, along with clinical features and MRI findings, is crucial for making a definitive diagnosis of Canavan Disease and guiding clinical decision-making.